Clinical Trial Update: Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

This trial entry documents a Phase 1 study evaluating fluphenazine in patients with relapsed or relapsed-and-refractory multiple myeloma. The trial status is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Fluphenazine (fluphenazine)

Snippet

Sponsor: Immune Control | Conditions: Multiple Myeloma | Phase 1 | Status: UNKNOWN